证券日报网讯2月26日，南华仪器（300417）发布公告称，2025年12月25日至2026年2月24日，公司实际 控制人之一致行动人叶淑娟通过集中竞价累计减持443600股，占公司总股本0.33%，其个人持股比例由 3.57%降至3.24%，实际控制人及一致行动人合计持股比例由22.30%降至21.97%。 ...

（文章来源：证券日报） 证券日报网讯 2月26日，南华仪器发布公告称，公司实际控制人杨耀光、杨伟光原签订的《一致行动协 议》已到期，为保证对公司的合法有效控制，保障公司的持续稳健发展，确保正确经营决策，2026年2 月25日，上述二人续签了《一致行动协议》。 ...

格隆汇2月26日丨南华仪器(300417.SZ)公布，实际控制人杨耀光、杨伟光原签订的《一致行动协议》已 到期，为保证对公司的合法有效控制，保障公司的持续稳健发展，确保正确经营决策，2026年2月25 日，上述二人续签了《一致行动协议》。 ...

股票代码：300417 股票简称：南华仪器 公告编号：2026-002 佛山市南华仪器股份有限公司 关于实际控制人续签一致行动协议的公告 义务时始终保持一致的意思表示，采取一致行动： 1、双方作为公司股东，就有关公司经营决策、董事提名选举和其它相关事 项在公司的各种股东大会、临时股东大会和其他股东会议中行使提案权和表决权 前，应先行与另一方进行充分沟通协商并达成一致意见，在对股东大会行使提案 权和表决权时应采取一致行动，根据关联交易管理制度需回避者除外； 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 佛山市南华仪器股份有限公司（以下简称"公司"或"南华仪器"）实际控 制人杨耀光、杨伟光原签订的《一致行动协议》已到期，为保证对公司的合法有 效控制，保障公司的持续稳健发展，确保正确经营决策，2026 年 2 月 25 日，上 述二人续签了《一致行动协议》。相关情况如下： 一、前次签订一致行动人协议的情况 2020 年 2 月 16 日，杨耀光和杨伟光签署了《一致行动协议》，依据该协议， 双方承诺和保证在该协议生效后，依据《中华人民共和国公司法》等有关法律法 规和 ...

股票代码：300417 股票简称：南华仪器 公告编号：2026-003 佛山市南华仪器股份有限公司 关于实际控制人之一致行动人减持股份触及 1%刻度的公告 本公司实际控制人之一致行动人叶淑娟女士保证向公司提供的信息披露内 容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 杨耀光持有股份 16,616,000 12.35% 16,616,000 12.35% 其中：无限售条件股 份 4,154,000 3.09% 4,154,000 3.09% 有限售条件股份 12,462,000 9.26% 12,462,000 9.26% 杨伟光持有股份 8,580,940 6.38% 8,580,940 6.38% 其中：无限售条件股 份 2,145,235 1.59% 2,145,235 1.59% 有限售条件股份 6,435,705 4.78% 6,435,705 4.78% 合计持有股份 30,003,680 22.30% 29,560,080 21.97% 其中：无限售条件股 份 7,500,920 5.57% 7,120,020 1.59% 有限售条件股份 22,502,760 16.72% 22,44 ...

公司项目推进 公司在2025年三季报沟通中提及，并购嘉得力项目正在积极推进流程，争取尽快完成交割。 以上内容基于公开资料整理，不构成投资建议。 经济观察网南华仪器（300417）预计2025年全年归属净利润亏损200万元至300万元，扣非净利润亏损 700万元至800万元，公司2025年年度报告将在后续披露。 业绩经营情况 根据南华仪器2026年1月30日发布的业绩预告，公司预计2025年全年归属净利润亏损200万元至300万 元，扣非净利润亏损700万元至800万元。 ...

Core Viewpoint - The article analyzes the 2025 performance forecasts of 22 domestic listed instrument companies, highlighting the divergence in performance and the impact of various market factors on the industry [2]. Group 1: Industry Overview - The overall operating conditions of the domestic instrument industry are gradually becoming clearer as companies disclose their 2025 performance forecasts [2]. - Among the 22 companies, 11 reported profits while 11 incurred losses; 8 of the profitable companies experienced year-on-year growth, while 3 saw stable or slightly fluctuating profits [2]. - The performance divergence is attributed to factors such as fluctuations in downstream demand, intensified industry competition, policy changes, and global supply chain instability [2]. Group 2: Performance Statistics - The net profit statistics for the listed instrument companies indicate significant growth for several firms, with some achieving over 190% year-on-year increases [3][8]. - Notable performers include: - Aiko Optoelectronics: Net profit of 0.57-0.7 billion, up 262.52-345.20% from 0.1572 billion [3]. - Haineng Technology: Net profit of 0.41-0.44 billion, up 213.65-236.61% from 0.1307 billion [3]. - Wan Yi Technology: Net profit of 0.42-0.62 billion, up 191.52-330.34% from 0.1441 billion [3]. Group 3: Industry Trends - The industry is witnessing increased performance divergence, with a trend towards higher concentration as companies with core technologies and strategic layouts capture more market share [5]. - The ongoing domestic substitution is deepening, with high-end instruments becoming a key growth driver, supported by policy incentives for high-end scientific instruments and equipment upgrades [5]. - Companies focusing on high-end sectors, such as high-end industrial imaging and clinical diagnostics, are expected to benefit from these trends [5]. Group 4: Operational Strategies - Companies facing operational pressures are likely to improve performance by divesting loss-making businesses, optimizing asset structures, and enhancing management of receivables and inventory [6]. - Profit-making companies will continue to pursue refined management practices to consolidate their advantages and enhance risk resilience [6]. Group 5: Performance Categories - Companies achieving profit growth or turning losses into profits are primarily benefiting from asset impairment improvements and business structure optimizations [18]. - The companies in this category include: - Gaode Infrared: Successfully turned around from a loss to a profit [18]. - Xianhe Environmental: Achieved profitability through structural optimization [21]. - Zhengye Technology: Also turned from loss to profit due to similar improvements [22]. Group 6: Challenges Faced - Companies experiencing expanded losses or transitioning from profit to loss share common challenges, including reliance on single business lines and significant asset impairment pressures [30]. - The need for transformation is evident, as some companies are in the process of adjusting their business models, which may not yet yield sufficient revenue to offset declines in traditional business areas [30].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 一、本期业绩预计情况 1、业绩预告期间：2 0 2 5年1月1日至2 0 2 5年1 2月3 1日。 2、业绩预告情况：预计净利润为负值 （1）以区间数进行业绩预告的 二、与会计师事务所沟通情况 四、其他相关说明 本业绩预告是公司财务部门初步测算的结果，未经注册会计师审计。2 0 2 5年度业绩 的具体财务数据将在公司2 0 2 5年年度报告中详细披露,公司 将严格按照有关法律法规的要 求，及时做好信息披露工作。敬请广大投资者谨慎决策，注意投资风险。 特此公告。 佛山市南华仪器股份有限公司董事会 2 0 2 6 年0 1 月3 0日 本业绩预告相关财务数据未经注册会计师审计。但公司已就业绩预告有关事项与年报 审计会计师事务所进行了预沟通，公司与会计师事务所在 本报告期的业绩预告方面不存在 重大分歧。 三、业绩变动原因说明 1、报告期内，归属于上市公司股东的净利润- 3 0 0万元至- 2 0 0万元，较上年同期下降， 主要原因为本报告期非经常性损益较上年同期较大幅度 减少，预计2 0 2 5年 ...

南财智讯1月30日电，南华仪器发布2025年度业绩预告，预计2025年全年归属于上市公司股东的净亏损 为200万元—300万元；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为-800万元 —-700万元，同比预增48.98%—55.36%。业绩变动原因说明：1、报告期内，归属于上市公司股东的净 利润-300万元至-200万元，较上年同期下降，主要原因为本报告期非经常性损益较上年同期较大幅度减 少，预计2025年非经常性损益约为500万元。2、报告期内，本年度扣除非经常性损益后的净利润预 计-800万元至-700万元，较上年同期增长，主要原因：（1）2025年，生态环境部等部门印发的《关于 机动车排放检验机构伪造排放检验结果或出具虚假排放检验报告情节严重判定标准的意见》及《关于进 一步优化机动车环境监管的意见》要求严格落实排放达标并强化监管要求，重视机动车排放检验领域第 三方机构专项整治工作，使机动车排放设备市场需求有所增加。（2）收购子公司引起公司合并范围变 更所致。 ...

Financial Projections - The estimated net profit for 2025 is projected to be between -3 million and -2 million CNY, a significant decrease compared to the previous year's profit of 14.77 million CNY[5] - The net profit after deducting non-recurring gains and losses is expected to be between -8 million and -7 million CNY, showing an increase compared to the previous year's loss of 15.68 million CNY[5] - The decrease in net profit is primarily due to a significant reduction in non-recurring gains and losses, estimated to be around 5 million CNY for 2025[7] Market Outlook - The company anticipates increased demand in the vehicle emission testing equipment market due to stricter regulatory requirements from the Ministry of Ecology and Environment[8] - The change in the scope of consolidation due to the acquisition of a subsidiary is also a contributing factor to the expected financial performance[8] Financial Reporting - The financial data in this earnings forecast has not been audited by a registered accounting firm[6] - The specific financial data for the 2025 fiscal year will be detailed in the company's annual report[9] - The company emphasizes the importance of timely information disclosure in accordance with relevant laws and regulations[9] Investor Guidance - Investors are advised to make cautious decisions and be aware of investment risks[9] - The earnings forecast period is from January 1, 2025, to December 31, 2025[3]